World J Gastrointest Pharmacol Therap 2017 84 208-209 Available from URL DOI First decision July 26 2017 Revised July 26 2017Accepted September 5 2017Article in press September 6 2017 Published online November 6 2017AbstractHalkjaer et al searched systematically nine articles in-TO THE EDITORI read with interest the article Can fecal microbiota transplantation cure irritable bowel syndrome1.

Submit a Manuscript DOI 10.4292wjgpt.v8.i4.208World J Gastrointest Pharmacol Ther 2017 November 6 84 208-209ISSN 2150-5349 onlineFecal microbiota transplantation against irritable bowel syndrome Rigorous randomized clinical trials are requiredAmin Talebi Bezmin AbadiAmin Talebi Bezmin Abadi Department of Bacteriology Faculty of Medical Science Tarbiat Modares University Tehran 14115 IranORCID number Amin Talebi Bezmin Abadi 0000-0001- 5209-6436.Author contributions Abadi ATB designed the paper andapproved the final manuscript.Conflict-of-interest statement All the authors declare that they have no competing interests.Open-Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers.

Can fecal microbiota transplantation cure irritable bowel syndrome World J Gastroenterol 2017 23 4112-4120 PMID 28652664 DOI 10.3748wjg.v23.i22.4112Talebi Bezmin Abadi A.

Route of delivery and optimum dosage are the major concerns to consider before using in clinical practice.Key words Fecal microbiota transplantation Irritable bowel syndrome Microbiota Dysbiosisc The Authors 2017.

Telephone 98-21-82884883Fax 98-21-82884883Received June 18 2017Peer-review started June 21 2017cluding 48 patients and concluded that fecal microbiota transplantation FMT can be an ideal treatment option for irritable bowel syndrome IBS subjects.

Fecal microbiota transplantation against irritable bowel syndrome Rigorous randomized clinical trials are required.

Fecal microbiota transplantation against IBSfor irritable bowel syndrome IBS subjects.

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome.

Aliment Pharmacol Ther 2017 45 764-765 PMID 28150451 DOI 10.1111apt.13926Sonnenberg A Turner KO Spechler SJ Genta RM.

Aliment Pharmacol Ther 2017 45 283-290 PMID 27862104 DOI 10.1111apt.13854Abadi AT Kusters JG.

